GlaxoSmithKline sales and marketing update

GlaxoSmithKline will discontinue the manufacture and sale of cancer drug Bexxar tositumomab, effective Feb. 20,

Read the full 158 word article

How to gain access

Continue reading with a
two-week free trial.